|
| 35195049 | CAPTURE ALS: the comprehensive analysis platform to understand, remedy and eliminate ALS. | Amyotroph Lateral Scler Frontotemporal Degener | 2023 |
| 37487605 | Use and misuse of research: Canada's response to covid-19 and its health inequalities. | BMJ | 2023 |
| 37487604 | How Canada's decentralised covid-19 response affected public health data and decision making. | BMJ | 2023 |
| 37334249 | Should Canada adopt managed access agreements in Canada for expensive drugs? | J Law Biosci | 2023 |
| 37462337 | What do people affected by amyotrophic lateral sclerosis want from health communications? Evidence from the ALS Talk Project. | Muscle Nerve | 2023 |
| 37064046 | Lessons from Canada's notice of compliance with conditions policy for the life-cycle regulation of drugs. | J Law Biosci | 2023 |
| 36692918 | Can Managed Access Agreements Mitigate Evidentiary, Economic and Ethical Issues with Access to Expensive Drugs for Rare Diseases in the Canadian Context? | Healthc Pap | 2023 |
| 36111949 | Amyotrophic lateral sclerosis (ALS) health charities are central to ALS care: perspectives of Canadians affected by ALS. | Amyotroph Lateral Scler Frontotemporal Degener | 2023 |
| 35186979 | Conditional Drug Approval as a Path to Market for Oncology Drugs in Canada: Challenges and Recommendations for Assessing Eligibility and Regulatory Responsiveness. | Front Med (Lausanne) | 2022 |
| 35413805 | Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis. | BMC Neurol | 2022 |
| 36284134 | A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada. | NPJ Precis Oncol | 2022 |
| 35945126 | Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers. | Can J Diabetes | 2022 |
| 35319446 | The Importance of and Challenges with Adopting Life-Cycle Regulation and Reimbursement in Canada. | Healthc Policy | 2022 |
| 34048692 | ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update. | Stem Cell Reports | 2021 |
| 34421792 | Communication About End of Life for Patients Living With Amyotrophic Lateral Sclerosis: A Scoping Review of the Empirical Evidence. | Front Neurol | 2021 |
| 32178652 | Application of protection motivation theory to clinical trial enrolment for pediatric chronic conditions. | BMC Pediatr | 2020 |
| 31959155 | Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment. | BMC Public Health | 2020 |
| 30994059 | Medical Information Commons to Support Learning Healthcare Systems: Examples From Canada. | J Law Med Ethics | 2019 |
| 31836632 | Monitoring progress toward United Nations commitments: characteristics of Canadian legislation to promote tobacco control, physical activity and healthy eating. A descriptive study. | CMAJ Open | 2019 |
| 31269854 | Participant perspectives on a phase I/II ocular gene therapy trial (NCT02077361). | Ophthalmic Genet | 2019 |
| 31355201 | Canada's <i>Assisted Human Reproduction Act:</i> Pragmatic Reforms in Support of Research. | Front Med (Lausanne) | 2019 |
| 30984761 | Recommendations for Regulating the Environmental Risk of Shedding for Gene Therapy and Oncolytic Viruses in Canada. | Front Med (Lausanne) | 2019 |
| 30994067 | Importance of Participant-Centricity and Trust for a Sustainable Medical Information Commons. | J Law Med Ethics | 2019 |
| 30102688 | Provenance and risk in transfer of biological materials. | PLoS Biol | 2018 |
| 28062017 | Non-invasive Prenatal Testing and the Unveiling of an Impaired Translation Process. | J Obstet Gynaecol Can | 2017 |
| 29868182 | Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges. | J Law Biosci | 2017 |
| 28416287 | Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications. | Stem Cell Reports | 2017 |
| 28938910 | Creating a data resource: what will it take to build a medical information commons? | Genome Med | 2017 |
| 29163494 | Reproducibility and Reuse of Adaptive Immune Receptor Repertoire Data. | Front Immunol | 2017 |
| 28946923 | Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic. | Genome Med | 2017 |
| 28850001 | Opportunities and challenges for the cellular immunotherapy sector: a global landscape of clinical trials. | Regen Med | 2017 |
| 28929854 | L'éthique de la modification du génome en clinique : une dose de réalisme pour les leaders en santé. | Healthc Manage Forum | 2017 |
| 28929852 | The ethics of genome editing in the clinic: A dose of realism for healthcare leaders. | Healthc Manage Forum | 2017 |
| 28839064 | Fostering reproducibility in industry-academia research. | Science | 2017 |
| 28861415 | More Haste, Less Speed: Could Public-Private Partnerships Advance Cellular Immunotherapies? | Front Med (Lausanne) | 2017 |
| 26876790 | Cell therapy licensing: a web for the unwary in Kimble v. Marvel Entertainment? | Regen Med | 2016 |
| 26432702 | Stepping Into and Out of the Void: Funding Dynamics of Human Embryonic Stem Cell Research in California, Sweden, and South Korea. | Stem Cell Rev Rep | 2016 |
| 26563511 | Sustaining large-scale infrastructure to promote pre-competitive biomedical research: lessons from mouse genomics. | N Biotechnol | 2016 |
| 27774240 | The mouse that trolled (again). | J Law Biosci | 2016 |
| 27463361 | DNA barcoding in the media: does coverage of cool science reflect its social context? | Genome | 2016 |
| 26855058 | Choroideremia research: Report and perspectives on the second international scientific symposium for choroideremia. | Ophthalmic Genet | 2016 |
| 25646804 | Use and misuse of material transfer agreements: lessons in proportionality from research, repositories, and litigation. | PLoS Biol | 2015 |
| 26594384 | The Mouse That Trolled: The Long and Tortuous History of a Gene Mutation Patent That Became an Expensive Impediment to Alzheimer's Research. | J Law Biosci | 2015 |
| 26565607 | Bringing regenerative medicines to the clinic: the future for regulation and reimbursement. | Regen Med | 2015 |
| 26285195 | "If they tell me to get it, I'll get it. If they don't...": Immunization decision-making processes of immigrant mothers. | Can J Public Health | 2015 |
| 26237706 | Current practices and reform proposals for the regulation of advanced medicinal products in Canada. | Regen Med | 2015 |
| 26032192 | Communicating the promise for ocular gene therapies: challenges and recommendations. | Am J Ophthalmol | 2015 |
| 25993942 | Drugs: Regulate 'home-brew' opiates. | Nature | 2015 |
| 25658278 | Keeping score, strengthening policy and fighting bad actors over access to research tools. | Nat Biotechnol | 2015 |
| 24236476 | The global landscape of stem cell clinical trials. | Regen Med | 2014 |